Bioactive peptides: New challenges and opportunities for the dairy industry

Australian Journal of Dairy Technology

Volumn 58, Issue 2, 2003, Pages 129-134

  Korhonen, Hannu ^a   Pihlanto, Anne ^a  

^a FINNISH FOREST RESEARCH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DIGESTIVE SYSTEM; ENZYMES; FERMENTATION; HEALTH CARE; NUTRITION; PHYSIOLOGY;

HEALTH-PROMOTING FOODS;

DAIRY PRODUCTS;

EID: 0141482038     PISSN: 00049433     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (86)

1. Adamson, N.J. and Reynolds, E.C. (1995), Characterization of tryptic casein phosphopeptides prepared under industrially relevant conditions. Biotechnol. Bioeng. 45, 196-204.
2. Addeo, F., Chianes, L., Salzano, A., Sacchi, R., Cappuccio, U., Ferranti, P. and Malorni, A. (1992), Characterization of the 12% tricholoroacetic acid-insoluble oligopeptides of Parmigiano-Reggiano cheese. J. Dairy Res. 59, 401-411.
3. Ariyoshi, Y. (1993), Angiotensin-converting enzyme inhibitors derived from food proteins. Trends Food Sci. Technol. 4, 139-144.
4. Bastian, E.D. and Brown, R.J. (1996), Plasmin in milk and dairy products: an update. Int. Dairy J. 6, 435-457.
5. Bienenstock, J., Wiley, R.E., Neigh, G.S., Waserman, S. and Keith, P. (2002), Probiotics in the management and prevention of atopy. Clin. Rev. Allergy Immun. 22, 275-285.
6. Bordenave, S., Sannier, F., Ricart, G. and Piot, J.M. (1999), Continuous hydrolysis of goat whey in an ultrafiltration reactor: Generation of alpha-lactorphin. Prep. Biochem. Biotechnol. 29, 189-202.
7. Bouhallab, S., Molle, D. and Leonil, J. (1992), Tryptic hydrolysis of caseinomacropeptide in membrane reactor: Preparation of bioactive peptides. Biotechnol. Lett. 14, 805-810.
8. Bouhallab, S. and Touzé, C. (1995), Continuous hydrolysis of caseinomactopeptide in a membrane reactor: kinetic study and gram-scale production of antithrombotic peptides. Lait 75, 251-258.
9. Christensen, J.E., Dudley, E.G., Pederson, J.A. and Steele, J.L. (1999), Peptidases and amino acid catabolism in lactic acid bacteria. Antonie van Leeuwenhoek 76, 217-246.
10. Clare, D.A. and Swaisgood, H.E. (2000), Bioactive milk peptides: A prospectus. J. Dairy Sci. 83, 1187-1195.
11. D'Alvise, N., Lesueur-Lambert, C., Fertin, B., Dhulster, P. and Guillochon, D. (2000), Hydrolysis and large scale ultrafiltration study of alfalfa protein concentrate enzymatic hydrolysate. Enzyme Microb. Technol. 27, 286-294.
12. Darragh, A.G. (2002), Physiological impact of milk protein-encrypted bioactive peptides. IDF Bulletin 375, 25-31.
13. de Wit, J.N. (1989), Functional properties of whey proteins. In: Developments in Dairy Chemistry - 4 (Ed. Fox, P.F.), London, Elsevier Science Publishers, pp. 285-321.
14. de Wit, J.N. (1998), Nutritional and Functional characteristics of whey proteins in food products. J. Dairy Sci. 81, 597-608.
15. Dionysius, D.A., Marschke, R.J., Wood, A.J., Milne, J., Beattie, T.R., Jiang, H., Treloar, T., Alewood, P.F. and Grieve, P.A. (2000), Identification of physiologically functional peptides in dairy products. Aust. J. Dairy Technol. 55, 103.
16. Dziuba, J., Minkiewicz, P. and Nalecz, D. (1999), Biologically active peptides from plant and animal proteins. Pol. J. Food Nutr. Sci. 8/49, 3-16.
17. Ellegård, K.H., Gammelgård-Larsen, C., Sorensen, E.S. and Fedosov, S. (1999), Process scale Chromatographic isolation, characterization and identification of tryptic bioactive casein phosphopeptides. Int. Dairy J. 9, 639-652.
18. FitzGerald, R.J. (1998), Potential uses of caseinophosphopeptides. Int. Dairy J. 8, 451-457.
19. Gagnaire, V., Molle, D., Herrouin, M. and Leonil, J. (2001), Peptides identified during Emmental cheese ripening: Origin and proteolytic systems involved. J. Agric. Food Chem. 49, 4402-4413.
20. Gauthier, S.F. and Pouliot, M. (1996), Use of ultrafiltration for the preparation of enzymatic hydrolysates from milk proteins. IDF Bulletin 311, 31-32.
21. Gobbetti, M., Ferranti, P., Smacchi, E., Goffredi, F. and Addeo, F. (2000), Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Appl. Environ. Microbiol. 66, 3898-3904.
22. Gobbetti, M., Stepaniak, L., De Angelis, M., Corsetti, A. and Di Cagno, R. (2002), Latent bioactive peptides in milk proteins: proteolytic activation and significance in dairy processing. Crit. Rev. Food Sci. Nutr. 42 (3), 223-239.
23. Gomez-Ruiz, J.A., Ramos, M. and Recio, I. (2002), Angiotensin-converting enzyme-inhibitory peptides in Manchego cheese manufactured with different starter cultures. Int. Dairy J. 12, 697-706.
24. Haileselassie, S.S., Lee, B.H. and Gibbs, B.F. (1999), Purification and identification of potentially bioactive peptides from enzyme-modified cheese. J. Dairy Sci. 82, 1612-1617.
25. Hata, Y., Yamamoto, M., Ohni, H., Nakajima, K., Nakamura, Y. and Takano, T. (1996), A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am. J. Clin. Nutr. 64, 767-771.
26. Hurley, M.J., Larsen, L.B., Kelly, A.L. and McSweeney, P.L.H. (2000), The milk acid proteinase cathepsin D: a review. Int. Dairy J. 10, 673-681.
27. Jelen, P. and Lutz, S. (1998), Functional milk and dairy products. In: Functional Foods, Biochemical & Processing Aspects (Ed: Mazza, G.), Lancaster: Technomic. p 357-80.
28. Jost, R. (1993), Functional characteristics of dairy proteins. Trends Food Sci. Technol. 4, 283-288.
29. Kelly, P.M. and McDonagh, D. (2000), Innovative dairy ingredients. World Food Ingred. October/November, 24-32.
30. Kinsella, J.E. and Whitehead, D.M. (1989), Proteins in whey: chemical, physical, and functional properties. Adv. Food and Nutr. Res. 33, 343-438.
31. Kirjavainen, P.V., Apostolou, E., Salminen, S.J. and Isolauri, E. (1999), New aspects of probiotics - a novel approach in the management of food allergy. Allergy 54, 909-915.
32. Klink, L. (2002), Milk-derived bioactives. World Food Ingred. September, 28-35.
33. Korhonen, H. (2002), Technology options for new nutritional concepts. Int. J. Dairy Technol. 55, 79-88.
34. Korhonen, H., Marnila, P., Pihlanto-Leppälä, A. and Ryhänen, E.-L. (2001), Bioactive components of milk: Natural ingredients for health promotion. Innovations Food Technol. February/March, 23-27.
35. Korhonen, H. and Pihlanto-Leppälä, A. (2001), Milk protein-derived bioactive peptides - Novel opportunities for health promotion. IDF Bulletin 363, 17-26.
36. Korhonen, H., Pihlanto-Leppälä, A., Rantamäki, P. and Tupasela, T. (1998a), The functional and biological properties of whey proteins: prospects for the development of functional foods. Agr. Food Sci. Finland 7, 283-296.
37. Korhonen, H., Pihlanto-Leppälä, A., Rantamäki, P. and Tupasela, T. (1998b), Impact of processing on bioactive proteins and peptides. Trends Food Sci. Technol. 9, 307-319.
38. Kudoh, Y., Matsuda, S., Igoshi, K. and Oki, T. (2001), Antioxidative peptide from milk fermented with Lactobacillus delbrueckii subsp. bulgaricus IFO13953. J. Jpn Soc. Food Sci. 48, 44-50.
39. LeBlanc, J.G., Matar, C., Valdéz, J.C., LeBlanc, J. and Perdigon, G. (2002), Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J. Dairy Sci. 85, 2733-2742.
40. Marnila, P., Korhonen, H., (2002), Colostrum. In: Encyclopedia of Dairy Sciences (Eds. Roginski, H., Fuquay, J.W. and Fox, P.F.), Academic Press, London pp. 473-478.
41. Martin-Orue, C., Henry, G. and Bouhallab, S. (1999), Tryptic hydrolysis of κ-caseinomacropeptide: Control of the enzymatic reaction in a continuous membrane reactor. Enzyme Microb. Technol. 24, 173-180.
42. Matar, C., Valdez, J.C., Medina, M., Rachid, M. and Perdigon, G. (2001), Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J. Dairy Res. 68, 601-609.
43. McDonagh, D. and FitzGerald, R.J. (1998), Production of caseinophosphopeptides (CPPs) from sodium caseinate using a range of commercial protease preparations. Int. Dairy J. 8, 39-45.
44. McIntosh, G.H., Royle, P.J., Le Leu, R.K., Regester, G.O., Johnson, M.A., Grinsted, R.L., Kenward, R.S. and Smithers, G.W. (1998), Whey proteins as functional ingredients? Int. Dairy J. 8, 425-434.
45. Meisel, H. (1998), Overview on milk-protein-derived peptides. Int. Dairy J. 8, 363-373.
46. Meisel, H. (2001), Bioactive peptides from milk proteins: a perspective for consumers and producers. Aust. J. Dairy Technol. 56, 83-92.
47. Meisel, H. and Bockelmann, W. (1999), Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties. Antonie van Leeuwenhoek 76, 207-215.
48. Meisel, H., Goepfert, A. and Gunther, S. (1997), ACE inhibitory activities in milk products. Milchwissenschaft 52, 307-311.
49. Morr, C.V. and Ha, E.Y.V. (1993), Whey protein concentrates and isolates: Processing and functional properties. CRC Crit. Rev. Food Sci. Nutr. 6, 431-476.
50. Mullally, M.M., Meisel, H. and FitzGerald, R.J. (1997), Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine β-lactoglobulin. FEBS Lett. 402, 99-101.
51. Mulvihill, D.M. and Fox, P.F. (1989), Physico-chemical and functional properties of milk proteins. In: Developments in Dairy Chemistry - 4 (Ed. Fox, P.F.), London: Elsevier Science Publishers, pp. 131-172.
52. Nagaoka, S., Futamura, Y., Miwa, K., Awano, T., Yamauchi, K., Kanamaru, Y., Tadashi, K. and Kuwata, T. (2001), Identification of novel hypocholesterolemic peptides derived from bovine milk β-lactoglobulin. Biochem. Biophys. Res. Commun. 281, 11-17.
53. Nakamura, Y., Yamamoto, M., Sakai, K., Okubo, A., Yamazaki, S. and Takano, T. (1995), Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J. Dairy Sci. 78, 777-783.
54. Pakkanen, R. and Aalto, J. (1997), Growth factors and antimicrobial factors of bovine colostrum. Int. Dairy J. 7, 285-297.
55. Perea, A. and Ugalde, U. (1996), Continuous hydrolysis of whey proteins in a membrane recycle reactor. Emzyme Microb. 18, 29-34.
56. Pihlanto-Leppälä, A. (2001), Bioactive peptides derived from bovine whey proteins: opioid and ACE-inhibitory peptides. Trends Food Sci. Technol. 11, 347-356.
57. Pihlanto-Leppälä, A., Koskinen, P., Paakkari, I., Tupasela, T. and Korhonen, H. (1996), Opioid whey protein peptides obtained by membrane filtration. IDF Bulletin 311, 36-38.
58. Pihlanto-Leppälä, A., Koskinen, P., Piilola, K., Tupasela, T. and Korhonen H. (2000), Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. J. Dairy Res. 67, 53-64.
59. Pihlanto-Leppälä, A., Rokka, T. and Korhonen, H. (1998), Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int. Dairy J. 8, 325-331.
60. Playford, R.J., Macdonald, C.E. and Johnson, W.S. (2000), Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. Am. J. Clin. Nutr. 12, 5-14.
61. Recio, I., Floris, R. and Visser, S. (2000), Bioactive peptides from food proteins: A new isolation method. Agro-Food- Industry Hi-Tech, 2, 9-11.
62. Recio, I. and Visser, S. (1999), Two ion-exchange Chromatographic methods for the isolation of antibacterial peptides from lactoferrin. In situ enzymatic hydrolysis on an ion-exchange membrane. J. Chromatography 831, 191-201.
63. Reynolds, E.C. (1992), Production of phosphopeptides from casein. World Patent Application WO 92/18526.
64. Righetti, P.G., Nembri, F., Bossi, A. and Mortarino, M. (1997), Continuous enzymatic hydrolysis of β-casein and isoelectric collection of some of the biologically active peptides in an electric field. Biotechnol. Progr. 13, 258-264.
65. Rokka, T., Syväoja, E.L., Tuominen, J. and Korhonen, H. (1997), Release of bioactive peptides by enzymatic proteolysis of Lactobacillus GG fermented UHT-milk. Milchwissenschaft 52, 675-678.
66. Roudot-Algaron, F., LeBars, D., Kerhoas, L., Einhorn, J. and Gripon, J.C. (1994), Phosphopeptides from Comté cheese: nature and origin. J. Food Sci. 59, 544-547.
67. Ryhänen, E.L., Pihlanto-Leppälä, A. and Pahkala. E. (2001), A new type of ripened, low-fat cheese with bioactive properties. Int. Dairy J. 11, 441-447.
68. Saito, T., Nakamura, T., Kitazawa, H., Kawai, Y. and Itoh, T. (2000), Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. J. Dairy Sci. 83: 1434-1440.
69. Sannier, F., Bordenave, S. and Piot, J.M. (2000), Purification of goat beta-lactoglobulin from whey by an ultrafiltration membrane enzymic reactor. J. Dairy Res. 67, 43-51.
70. Schanbacher, F.L., Talhouk, R.S., Murray, F.A., Gherman, L.I. and Willet, L.B. (1998), Milk-borne bioactive peptides. Int. Dairy J. 8, 393-403.
71. Seppo, L., Jauhiainen, T., Poussa, T. and Korpela, R. (2003), A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 77, 326-330.
72. Shah, N.P. (2000), Effects of milk-derived bioactives: an overview. Br. J. Nutr. 84, S3-S10.
73. Singh, T.K., Fox, P.F. and Healy, A. (1997), Isolation and identification of further peptides in the diafiltration retentate of the water-soluble fraction of Cheddar cheese. J. Dairy Res. 64, 433-443.
74. Sipola, M., Finckenberg, P., Santisteban, J., Korpela, R., Vapaatalo, H. and Nurminen, M.L. (2001), Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J. Physiol. Pharmacol. 52, 745-754.
75. Sipola, M., Finckenberg, P., Korpela, R., Vapaatalo, H. and Nurminen, M.L. (2002), Effect of long-term intake of milk products on blood pressure in hypertensive rats. J. Dairy Res. 69, 103-111.
76. Smacchi, E. and Gobbetti, M. (1998), Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria, Psudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme. Emzyme Microb. Tech. 22, 687-694.
77. Smacchi, E. and Gobbetti, M. (2000), Bioactive peptides in dairy products: synthesis and interaction with proteolytic enzymes. Food Microbiology 17, 129-141.
78. Steijns, J.M. (2001), Milk ingredients as nutraceuticals. Int. J. Dairy Technol. 54: 81-88.
79. Sütas, Y., Soppi, E., Korhonen, H., Syväoja, E.L., Saxelin, M., Rokka, T. and Isolauri, E. (1996), Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes. J. Allergy Clin. Immun. 98, 216-224.
80. Takano, T. (2002), Anti-hypertensive activity of fermented dairy products containing biogenic peptides. Antonie van Leeuwenhoek 82, 333-340.
81. Tolkach, A., Thomä, C., Kersten, M. and Kulozik, U. (2002), Membrane separation concentrating health-relevant components from complex systems. G.I.T. Lab. J. 4, 172-174.
82. Turgeon, S.L. and Gauthier, S.F. (1990), Whey peptide fractions obtained with a two-step ultrafiltration process: Production and characterization. J. Food Sci. 55, 106-110.
83. Visser, S., Noorman, H.J., Slangen, C.J. and Rollema, H.S. (1989), Action of plasmin on bovine β-casein in a membrane reactor. J. Dairy Res. 56, 323-333.
84. Walzem, R.L., Dillard, C.J. and German, J.B. (2002), Whey components: millennia of evolution create functionalities for mammalian nutrition: what we know and what we may be overlooking. Crit. Rev. Food Sci. Nutr. 42 (4), 353-375.
85. Yamamoto, N., Maeno, M. and Takano, T. (1999), Purification and characterization of an antihypertensive peptide from a yoghurt-like product fermented by Lactobacillus helveticus CPN4. J. Dairy Sci. 82, 1388-1393.
86. Yamamoto, N. and Takano, T. (1999), Antihypertensive peptides derived from milk proteins. Nahrung 43, 159-164.